KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Non-Current Assets (2016 - 2026)

Zimmer Biomet Holdings has reported Non-Current Assets over the past 18 years, most recently at $17.8 billion for Q1 2026.

  • For Q1 2026, Non-Current Assets rose 7.02% year-over-year to $17.8 billion; the TTM value through Mar 2026 reached $71.2 billion, up 6.22%, while the annual FY2025 figure was $18.0 billion, 7.66% up from the prior year.
  • Non-Current Assets for Q1 2026 was $17.8 billion at Zimmer Biomet Holdings, down from $18.0 billion in the prior quarter.
  • Over five years, Non-Current Assets peaked at $18.0 billion in Q4 2025 and troughed at $16.6 billion in Q1 2025.
  • A 5-year average of $17.1 billion and a median of $16.9 billion in 2024 define the central range for Non-Current Assets.
  • Biggest five-year swings in Non-Current Assets: fell 10.41% in 2022 and later rose 7.66% in 2025.
  • Year by year, Non-Current Assets stood at $16.6 billion in 2022, then increased by 1.49% to $16.9 billion in 2023, then decreased by 1.15% to $16.7 billion in 2024, then rose by 7.66% to $18.0 billion in 2025, then fell by 1.18% to $17.8 billion in 2026.
  • Business Quant data shows Non-Current Assets for ZBH at $17.8 billion in Q1 2026, $18.0 billion in Q4 2025, and $17.7 billion in Q3 2025.